You are subscribed to the Drug Topics Hospital Pharmacists' Report. Unsubscribe here..

Drug Topics Hospital Pharmacists' Report

Print Subscribe

Digital Edition Subscribe

October 18, 2012

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Congressmen ask DOJ to investigate meningitis cases

Two lawmakers are asking the U.S. Department of Justice to open a criminal investigation to determine if the New England Compounding Center violated any state or federal laws, directly contributing to the contamination of steroid products that were distributed to more than 20 states. » More

Continuing Education

New CPE Series: October activity available now

Welcome to the second activity of our new CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 CPE credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The October activity will cover medical nutrition therapy, physical activity, and health maintenance considerations for patients with diabetes.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

TODAY'S HEADLINES

Restarting warfarin after GIB is beneficial

Patients taking long-term warfarin who had bleeding from their gastrointestinal tract should probably resume warfarin once the bleeding episode is under control to reduce their risk of thrombosis, according to a study published Sept. 18 online in the Archives of Internal Medicine. » More

FDA fast-tracks delafloxacin

FDA has granted delafloxacin (Rib-X) as a Qualified Infectious Disease Product for the indications of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. » More

Combination therapy provides rapid sedation

Use of concurrent sedating agents provides rapid sedation and reduces the need for resedation in acutely agitated patients, according to clinical trial results published online Sept. 14 in the Annals of Emergency Medicine. » More

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out, too

FDA: Other NECC drugs now questionable

HRT can reduce CVD risk after menopause

Medication reconciliation tool available

USP: New Rx labeling guides in November

Voices

Anticoagulation Update

JP at Large: Pharmacists are Job 1

View from the Zoo: Feeling like a real pharmacist

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group